P2Y12 INHIBITOR MONOTHERAPY VS. ASPIRIN MONOTHERAPY AFTER SHORT-TERM DUAL ANTIPLATELET THERAPY IN ELDERLY PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM A NETWORK META-ANALYSIS OF RANDOMIZED TRIALS

被引：0
|
作者：
Uchiyama, Shuhei [1 ]
Ueyama, Hiroki [1 ]
Kuno, Toshiki [1 ]
Takagi, Hisato [2 ]
机构：
[1] Mt Sinai Beth Israel Hosp, Med, New York, NY USA
[2] Kokuritsu Byoin Kiko Shizuoka Iryo Ctr, Cardiovasc Surg, Shizuoka, Japan
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2021年 / 36卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S152 / S153
页数：2
相关论文
共 50 条
  • [11] P2Y12 Inhibitor Monotherapy Versus Aspirin Monotherapy After 12 Months of DAPT in Patients Undergoing Percutaneous Coronary Intervention: A Meta-analysis
    Rahman, Hammad Ur
    Khan, Muhammad Aslam
    Lone, Ahmad
    Ghosh, Priyanka
    Hammad, Tehseen
    Sattur, Sudhakar
    Kaluski, Edo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (04) : S15 - S15
  • [12] Meta-Analysis of the Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Short Course of Dual-Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
    Elzanaty, Ahmed M.
    Nazir, Salik
    Awad, Mohammed T.
    Elsheikh, Eman
    Ahuja, Keerat Rai
    Donato, Anthony
    Eltahawy, Ehab A.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2020, 21 (12) : 1500 - 1506
  • [13] P2Y12 INHIBITOR MONOTHERAPY OR DUAL ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH HYPERTENSION
    Pil-Sang, Song
    Jin-Ok, Jeong
    JOURNAL OF HYPERTENSION, 2023, 41 : E178 - E178
  • [14] Short Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy versus 1-Year Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Joseph, Meghna
    Krishna, Mrinal Murali
    Ezenna, Chidubem
    Pereira, Vinicius
    Franco, Ancy Jenil
    Goldsweig, Andrew
    CIRCULATION, 2024, 150
  • [15] Meta-analysis of Dual Antiplatelet Therapy Versus Monotherapy With P2Y12 Inhibitors in Patients After Percutaneous Coronary Intervention
    Malik, Aaqib H.
    Yandrapalli, Srikanth
    Shetty, Suchith S.
    Aronow, Wilbert S.
    Cooper, Howard A.
    Panza, Julio A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 127 : 25 - 29
  • [16] P2Y12 inhibitors monotherapy after short course of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials including 29 089 patients
    Bianco, Matteo
    Careggio, Alessandro
    Destefanis, Paola
    Luciano, Alessia
    Perrelli, Maria Giulia
    Quadri, Giorgio
    Rossini, Roberta
    Campo, Gianluca
    Vizzari, Giampiero
    D'Ascenzo, Fabrizio
    Anselmino, Matteo
    Biondi-Zoccai, Giuseppe
    Ibanez, Borja
    Montagna, Laura
    Varbella, Ferdinando
    Cerrato, Enrico
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : 196 - 205
  • [17] P2Y12 Inhibitor Monotherapy vs. Dual Antiplatelet Therapy
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1156 - 1156
  • [18] Short-term dual antiplatelet therapy (DAPT) followed by P2Y12 monotherapy versus traditional DAPT in patients undergoing percutaneous coronary intervention: meta-analysis and viewpoint
    Wernly, Bernhard
    Rezar, Richard
    Gurbel, Paul
    Jung, Christian
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (01) : 173 - 176
  • [19] Short-term dual antiplatelet therapy (DAPT) followed by P2Y12 monotherapy versus traditional DAPT in patients undergoing percutaneous coronary intervention: meta-analysis and viewpoint
    Bernhard Wernly
    Richard Rezar
    Paul Gurbel
    Christian Jung
    Journal of Thrombosis and Thrombolysis, 2020, 49 : 173 - 176
  • [20] P2Y12 Inhibitor Monotherapy After Short-Term Dual Antiplatelet Therapy in Acute Coronary Syndrome
    Singh, Sahib
    Garg, Aakash
    Tantry, Udaya S.
    Bliden, Kevin
    Abbott, J. Dawn
    Gurbel, Paul A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 224 : 1 - 8
12345